Latest News
The American Heart Association has honored Daniela Renedo, MD a postdoctoral fellow in the departments of Neurosurgery and Neurology, with the Stroke Basic Science Award for excellence in cerebrovascular disease research.
- April 29, 2019
The School of Medicine will be a major participant in the planning and operation of the $838 million facility, which will focus on innovation in the neurosciences and include two new patient facilities. Projected opening is in 2024.
- May 01, 2017Source: NH Register
Gene sequencing at Yale finding personalized root of disease; new center opens in West Haven
- March 05, 2017
Mark Youngblood, an MD/PhD student in the laboratory of Murat Gunel, has been selected to receive the Integra Foundation Award at this year's AANS meeting in Los Angeles.
- April 26, 2016
All classes and conferences at Yale School of Medicine will be cancelled on the afternoon of Tuesday, May 3 as the medical community gathers to celebrate one of its oldest annual traditions: Student Research Day.
- November 29, 2015
Gliomas can begin as benign growth in brain tissue but almost all eventually morph into malignant cancers called GBMs. Despite medical and surgical advances, GBMs remain one of the most deadly cancers in humans. In a comprehensive genomic study of gliomas that progressed into GBMs, an international team led by Yale Cancer Center researchers discovered the mechanisms that cause this transformation, findings that have implications about how the disease is treated.
- October 19, 2015
Four Yale faculty members were among 80 people worldwide elected to the National Academy of Medicine (formerly the Institute of Medicine), the academy announced Oct. 19.
- October 19, 2015
Yale Cancer Center's Dr. Murat Gunel has been named to the prestigious National Academy of Medicine.
- March 25, 2015
DNA mutations can cause cancer but in some cases, more mutations may mean a better prognosis for patients. A Yale-led comprehensive genomic analysis of more than 700 brain tumors has revealed one such subtype of the most malignant brain tumor, called glioblastoma, or GBM. This subtype possesses thousands of tumor-specific DNA errors or mutations instead of dozens observed in most glioblastoma cases. It is also associated with longer survival.
- February 05, 2015
Murat Günel, M.D., an accomplished neurosurgeon and geneticist, has been named chair of the School of Medicine’s Department of Neurosurgery and chief of neurosurgery at Yale-New Haven Hospital.